| Antibody–Fc/FcR interaction on macrophages as a mechanism for hyperprogressive disease in non–small cell lung cancer subsequent to PD-1/PD-L1 blockade G Lo Russo, M Moro, M Sommariva, V Cancila, M Boeri, G Centonze, ... Clinical Cancer Research 25 (3), 989-999, 2019 | 417 | 2019 |
| SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta F Facchetti, M Bugatti, E Drera, C Tripodo, E Sartori, V Cancila, ... EBioMedicine 59, 2020 | 311 | 2020 |
| Fasting-mimicking diet is safe and reshapes metabolism and antitumor immunity in patients with cancer C Vernieri, G Fucà, F Ligorio, V Huber, A Vingiani, F Iannelli, A Raimondi, ... Cancer Discovery 12 (1), 90-107, 2022 | 214 | 2022 |
| WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer L Castagnoli, V Cancila, SL Cordoba-Romero, S Faraci, G Talarico, ... Oncogene 38 (21), 4047-4060, 2019 | 186 | 2019 |
| Compromised nuclear envelope integrity drives TREX1-dependent DNA damage and tumor cell invasion GP de Freitas Nader, S Agüera-Gonzalez, F Routet, M Gratia, M Maurin, ... Cell 184 (20), 5230-5246. e22, 2021 | 168 | 2021 |
| Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson–Gilford Progeria Syndrome J Aguado, A Sola-Carvajal, V Cancila, G Revêchon, PF Ong, ... Nature communications 10 (1), 4990, 2019 | 119 | 2019 |
| NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance MR Emma, JL Iovanna, D Bachvarov, R Puleio, GR Loria, G Augello, ... Cell death & disease 7 (6), e2269-e2269, 2016 | 113 | 2016 |
| Drp1 controls effective T cell immune-surveillance by regulating T cell migration, proliferation, and cMyc-dependent metabolic reprogramming L Simula, I Pacella, A Colamatteo, C Procaccini, V Cancila, M Bordi, ... Cell reports 25 (11), 3059-3073. e10, 2018 | 107 | 2018 |
| Trabectedin overrides osteosarcoma differentiative block and reprograms the tumor immune environment enabling effective combination with immune checkpoint inhibitors C Ratti, L Botti, V Cancila, S Galvan, I Torselli, C Garofalo, MC Manara, ... Clinical Cancer Research 23 (17), 5149-5161, 2017 | 75 | 2017 |
| Circulating mir‐320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk O Fortunato, C Borzi, M Milione, G Centonze, D Conte, M Boeri, C Verri, ... International journal of cancer 144 (11), 2746-2761, 2019 | 73 | 2019 |
| Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome V Capaci, L Bascetta, M Fantuz, GV Beznoussenko, R Sommaggio, ... Nature communications 11 (1), 3945, 2020 | 71 | 2020 |
| Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomas A Di Napoli, L De Cecco, PP Piccaluga, M Navari, V Cancila, C Cippitelli, ... Modern Pathology 32 (2), 216-230, 2019 | 65 | 2019 |
| Breast cancer organoids model patient-specific response to drug treatment E Campaner, A Zannini, M Santorsola, D Bonazza, C Bottin, V Cancila, ... Cancers 12 (12), 3869, 2020 | 64 | 2020 |
| Cross-talk between myeloid-derived suppressor cells and mast cells mediates tumor-specific immunosuppression in prostate cancer E Jachetti, V Cancila, A Rigoni, L Bongiovanni, B Cappetti, B Belmonte, ... Cancer immunology research 6 (5), 552-565, 2018 | 60 | 2018 |
| ATR expands embryonic stem cell fate potential in response to replication stress S Atashpaz, S Samadi Shams, JM Gonzalez, E Sebestyen, ... Elife 9, e54756, 2020 | 50 | 2020 |
| Tissue fluidification promotes a cGAS–STING cytosolic DNA response in invasive breast cancer E Frittoli, A Palamidessi, F Iannelli, F Zanardi, S Villa, L Barzaghi, H Abdo, ... Nature materials 22 (5), 644-655, 2023 | 49 | 2023 |
| Infiltrating mast cell–mediated stimulation of estrogen receptor activity in breast cancer cells promotes the luminal phenotype MT Majorini, V Cancila, A Rigoni, L Botti, M Dugo, T Triulzi, L De Cecco, ... Cancer research 80 (11), 2311-2324, 2020 | 48 | 2020 |
| DNA damage response at telomeres boosts the transcription of SARS‐CoV‐2 receptor ACE2 during aging S Sepe, F Rossiello, V Cancila, F Iannelli, V Matti, G Cicio, M Cabrini, ... EMBO reports 23 (2), e53658, 2022 | 40 | 2022 |
| HER2 signaling and breast cancer stem cells: The bridge behind HER2-positive breast cancer aggressiveness and therapy refractoriness SM Pupa, F Ligorio, V Cancila, A Franceschini, C Tripodo, C Vernieri, ... Cancers 13 (19), 4778, 2021 | 39 | 2021 |
| PD‐1‐induced T cell exhaustion is controlled by a Drp1‐dependent mechanism L Simula, Y Antonucci, G Scarpelli, V Cancila, A Colamatteo, S Manni, ... Molecular oncology 16 (1), 188-205, 2022 | 36 | 2022 |
